GT
Gaius Therapeutics, Inc,
SEC filingBiotechnology · San Diego, CA
Amount raised$60Ksold at filing
Total offering$250K$190K still open
Investors in the raise2count reported to the SEC
FiledMay 14, 2026first sale May 7, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Christopher Joseph EmigDirector
Ben Joseph WangDirector
Adam Joseph KlieExecutive Officer
Michon Joseph PinnixDirector
Jesse Joseph SolvasonExecutive Officer, Director
Javid Joseph AceilExecutive Officer
Executive officers, directors and promoters as listed on the Form D.